Deraco M - Search Results

1

Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma.

Zaffaroni N, Costa A, Pennati M, De Marco C, Affini E, Madeo M, Erdas R, Cabras A, Kusamura S, Baratti D, Deraco M, Daidone MG. Zaffaroni N, et al. Among authors: deraco m. Cell Oncol. 2007;29(6):453-66. doi: 10.1155/2007/456839. Cell Oncol. 2007. PMID: 18032822 Free PMC article.

2

Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei.

Deraco M, Gronchi A, Mazzaferro V, Inglese MG, Pennacchioli E, Kusamura S, Rizzi M, Anselmi RA Jr, Vaglini M. Deraco M, et al. Tumori. 2002 Sep-Oct;88(5):370-5. doi: 10.1177/030089160208800504. Tumori. 2002. PMID: 12487553

3

Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.

Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S. Deraco M, et al. J Surg Oncol. 2003 Jul;83(3):147-53. doi: 10.1002/jso.10255. J Surg Oncol. 2003. PMID: 12827682 Clinical Trial.

4

[Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei].

Deraco M, Kusamura S, Gronchi A. Deraco M, et al. Tumori. 2003 Jul-Aug;89(4 Suppl):54-5. Tumori. 2003. PMID: 12903545 Italian.

5

[Peritoneal mesothelioma: results of a complicated and aggressive procedure incorporating peritonectomy and intraperitoneal hyperthermic chemotherapy, and prospects derived from bench-to-bedside research].

Deraco M, Kusamura S, Baratti D, Casali P, Zaffaroni N. Deraco M, et al. Tumori. 2003 Jul-Aug;89(4 Suppl):56-7. Tumori. 2003. PMID: 12903546 Clinical Trial. Italian.

6

Management of peritoneal surface component of ovarian cancer.

Deraco M, Raspagliesi F, Kusamura S. Deraco M, et al. Surg Oncol Clin N Am. 2003 Jul;12(3):561-83. doi: 10.1016/s1055-3207(03)00027-9. Surg Oncol Clin N Am. 2003. PMID: 14567018 Review.

7

Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei.

Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S. Deraco M, et al. Ann Surg Oncol. 2004 Apr;11(4):393-8. doi: 10.1245/ASO.2004.07.002. Ann Surg Oncol. 2004. PMID: 15070599 Clinical Trial.

8

Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients.

Rossi CR, Deraco M, De Simone M, Mocellin S, Pilati P, Foletto M, Cavaliere F, Kusamura S, Gronchi A, Lise M. Rossi CR, et al. Among authors: deraco m. Cancer. 2004 May 1;100(9):1943-50. doi: 10.1002/cncr.20192. Cancer. 2004. PMID: 15112276 Free article. Clinical Trial.

9

Uterine sarcoma treated by cytoreductive surgery and intraperitoneal hyperthermic perfusion: a feasiblity study.

Kusamura S, Raspagliesi F, Baratti D, Gronchi A, Casali P, Deraco M. Kusamura S, et al. Among authors: deraco m. J Chemother. 2004 Nov;16 Suppl 5:19-22. doi: 10.1080/1120009x.2004.11782376. J Chemother. 2004. PMID: 15675470

10

Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion.

Younan R, Kusamura S, Baratti D, Oliva GD, Costanzo P, Favaro M, Gavazzi C, Deraco M. Younan R, et al. Among authors: deraco m. Ann Surg Oncol. 2005 Nov;12(11):910-8. doi: 10.1245/ASO.2005.11.030. Epub 2005 Sep 21. Ann Surg Oncol. 2005. PMID: 16177862

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

227 results

Search Page